I too bought in because of acne and co. but reckon It's good for management to stay focused on Sofdra's launch and not risk being distracted by other potentials, their time will come. Any BP diligencers will undoubtedly examine those and factor, appropriate value, into their offer.IMO
GO BOT!
Ann: Botanix $40 Million Capital Raising for Sofdra Rollout, page-190
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
30.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $588.2M | |||
| Open | High | Low | Value | Volume |
| 30.5¢ | 31.0¢ | 30.0¢ | $2.131M | 7.020M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 18 | 504695 | 30.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.5¢ | 38124 | 3 |
View Market Depth
| Last trade - 16.10pm 24/06/2025 (20 minute delay) ? |
| BOT (ASX) Chart |